Corrupt Practices | Lawsuits

Big Pharma’s Criminal / Civil Settlements

ByVera Sharav August 28, 2012April 30, 2017

Full page photo

Full page photo2

Lawsuits

“The Check is in the Mail”- Lilly-Zyprexa settlement payments
August 11, 2006November 21, 2014

8, 362 consumers of Lilly’s top-selling drug that produces diabetes–among other life-threatening effects–can expect between $5,000 to "well over $100,000 a person" depending upon the harm suffered.

Read More “The Check is in the Mail”- Lilly-Zyprexa settlement payments
Lawsuits

Lawsuits, Just the Cost of Criminal Marketing of Antipsychotic Drugs
October 3, 2010November 21, 2014

"When you’re selling $1 billion a year or more of a drug, it’s very tempting for a company to just ignore the traffic ticket and keep speeding.”

Read More Lawsuits, Just the Cost of Criminal Marketing of Antipsychotic Drugs
Children Victimized | Concealed Data | Current Controversies | Miscellaneous | Psych Drugs

Antidepressant Makers Withhold Data on Children – Washington Post
October 26, 2006September 17, 2021

Antidepressant Makers Withhold Data on Children – Washington Post Thu, 29 Jan 2004 A front page article in The Washington Post addresses the key issue undermining public health and safety. Drug companies conceal unfavorable clinical trial findings: the tests failed to demonstrate that antidepressants are either safe or beneficial for…

Read More Antidepressant Makers Withhold Data on Children – Washington Post
Investigations

Pharma front ACSH: “Whiny Whistleblower of the Year Award”
January 3, 2006November 21, 2014

2005 was a year in which some of Big Pharma’s clandestine relationships with an army of bought-and- paid- for minions in academia,
government, congress, the media, and front organizations were uncovered–in courtrooms, investigative books, reports and films.

Read More Pharma front ACSH: “Whiny Whistleblower of the Year Award”
Bioweapon Experiments | Concealed Data | Conflict of Interest | Corrupted Science | Current Controversies | NIH -- Ethics Violations

Francis Collins, NIH Director Resigns After Lying Re: Funding Gain of Function Experiments
October 9, 2021November 24, 2021

Breitbart News reported that Francis Collins, director of the National Institutes of Health (NIH), announced his resignation on Tuesday, just weeks after documents exposed that he made “untruthful” comments about U.S. federal funding of gain-of-function research at the Wuhan Institute of Virology. Gary Ruskin, executive director of U.S. Right To Know,…

Read More Francis Collins, NIH Director Resigns After Lying Re: Funding Gain of Function Experiments
Investigations

Avandia, a Case of Deja Vu all over again
February 20, 2010March 22, 2018

Even worse, FDA officials, in collusion and collaboration with GSK, approved an unethical and exploitative clinical trial—TIDE, which is on-going.

Read More Avandia, a Case of Deja Vu all over again

Similar Posts